← All EFX analyses

Equifax Inc.

EFX · Industrials
A ★★★★ Buy
Jul 15, 2026 · Score 85 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $166.93
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $160.00 ($150.00–$170.00)
Target PriceOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $220.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+31.8%

Type A - Equifax Inc. (EFX) 20260715 Stock Analysis

📅 Equifax Key Upcoming Events

🏢 Step 1: Equifax Company Overview & Business Model

Q1-A1. What is Equifax?

Q1-A2. How Does Equifax Make Money?

Q1-A3. Equifax’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Equifax’s Competitors?

Q1-A5. Equifax Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Equifax’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Equifax Have a Durable Economic Moat?

Q2-A2. Is Equifax’s Growth Sustainable?

Q2-A3. How Does Equifax Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Equifax Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Equifax? (Margins & ROIC)

Q3-A3. What Drives Equifax’s Returns? (ROIC Breakdown)

Q3-A4. Are Equifax’s Earnings High Quality?

Q3-A5. Is Equifax’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Equifax Forensic Accounting & Dilution Review

Q4-A1. Does Equifax Have Accounting Red Flags?

Q4-A2. Is Equifax Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Equifax’s Cash Flow?

Q4-A4. Is Equifax Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Equifax Management & Shareholder Alignment

Q5-A1. Can You Trust Equifax’s Management? (Guidance Track Record)

Q5-A2. What Are Equifax Insiders Doing?

Q5-A3. Is Equifax’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Equifax Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Equifax Guidance

Q6-A2. What Is Equifax’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Equifax Catalysts & Price Triggers

Q7-A1. What Could Move Equifax Stock? (Top 3 Catalysts)

Q7-A2. Equifax’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Equifax Fairly Valued? Valuation Analysis

Q8-A1. Equifax’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Equifax vs Peers: Valuation Comparison

Q8-A3. Is Equifax Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Equifax? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Equifax? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Equifax’s Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Equifax? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Equifax?

Q9-A2. How Sensitive Is Equifax to the Economy?

Q9-A3. Equifax Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score Calculation

🎯 Step 10: Equifax Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Equifax? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Equifax’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Equifax’s Heavy Reliance on the U.S. Mortgage Market Its Biggest Weakness?

Q2: Can Equifax’s 18.6x Forward P/E Be Justified Given the Macroeconomic Headwinds in Hiring and Lending?

Q3: Is the $750 Million Acquisition of Círculo de Crédito a Strategic Necessity or an Overpriced Bolt-On?

Q4: Will the Equifax Cloud Transformation Truly Yield Structural Margin Expansion?

Q5: Can Consumer-Permissioned Data and Open Banking Render The Work Number Obsolete?

Q6: How Vulnerable is the Workforce Solutions Segment to a U.S. Macroeconomic Recession?

Q7: Is Equifax’s 3.0x Leverage Ratio a Threat to its Aggressive Share Repurchase Strategy?

Q8: Does the High Level of Capitalized Software Costs Distort Equifax’s True Profitability?

Q9: Will Regulatory Pressures from the CFPB Constrain U.S. Information Solutions Pricing Power?

Q10: Can EFX.AI Meaningfully Expand the Total Addressable Market for Equifax’s Core Products?

Equifax Inc. (EFX)